CLINICAL_TRIALS
trial_result
· 2018-05-18
Clinical Trial Update: EH301 for the Treatment of ALS [NA]
Summary
The clinical trial evaluating EH301 for amyotrophic lateral sclerosis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Elysium Health | Conditions: Amyotrophic Lateral Sclerosis | NA | Status: COMPLETED